Bloomberg Technology

Moderna Co-chair on Pending FDA Review of Covid Vaccine

Dec.15 — Noubar Afeyan,co-chair at Moderna Inc., discusses a pending review by the U.S. FDA of the company’s vaccine to prevent Covid-19. Afeyan speaks on “Bloomberg Technology.”

Published

on

Dec.15 — Noubar Afeyan,co-chair at Moderna Inc., discusses a pending review by the U.S. FDA of the company’s vaccine to prevent Covid-19. Afeyan speaks on “Bloomberg Technology.”

1 Comment

  1. MonuZ ZeFF

    December 16, 2020 at 12:40 am

    DONT TAKE THE VACCINE !!!!!!!!!!!!!! WHY NO LIABILITY ?? MR Noubar Afeyan DONT YOU TRUST THE VACCINE ?????

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version